Kezar Life Sciences (KZR) Non-Current Debt (2021 - 2025)
Historic Non-Current Debt for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $1.4 million.
- Kezar Life Sciences' Non-Current Debt fell 7835.88% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 7835.88%. This contributed to the annual value of $5.1 million for FY2024, which is 4924.02% down from last year.
- Latest data reveals that Kezar Life Sciences reported Non-Current Debt of $1.4 million as of Q3 2025, which was down 7835.88% from $2.6 million recorded in Q2 2025.
- Kezar Life Sciences' Non-Current Debt's 5-year high stood at $10.1 million during Q4 2023, with a 5-year trough of $1.4 million in Q3 2025.
- Over the past 5 years, Kezar Life Sciences' median Non-Current Debt value was $9.6 million (recorded in 2021), while the average stood at $7.8 million.
- In the last 5 years, Kezar Life Sciences' Non-Current Debt soared by 238.97% in 2023 and then tumbled by 7835.88% in 2025.
- Over the past 5 years, Kezar Life Sciences' Non-Current Debt (Quarter) stood at $9.6 million in 2021, then grew by 2.2% to $9.8 million in 2022, then rose by 2.39% to $10.1 million in 2023, then tumbled by 49.24% to $5.1 million in 2024, then tumbled by 73.12% to $1.4 million in 2025.
- Its Non-Current Debt was $1.4 million in Q3 2025, compared to $2.6 million in Q2 2025 and $3.9 million in Q1 2025.